These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38136295)

  • 1. New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma.
    Dalzell CG; Taylor AC; White SB
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
    Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
    Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial.
    Oliveira Ribeiro MC; Moda KA; Alvarez M; Koga KH; Moriguchi SM; Carvalho FC; Pinheiro RSN; Qi X; Romeiro FG
    Acad Radiol; 2024 May; 31(5):1839-1848. PubMed ID: 38016824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C; Lazarev S; Ru M; Kim E; Fischman A; Moshier E; Rosenzweig K; Buckstein M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):968-976. PubMed ID: 31536781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma.
    Shi Y; Zhai B
    Gastrointest Tumors; 2016 Oct; 3(2):90-102. PubMed ID: 27904861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.
    Sharma D; Khosla D; Meena BL; Yadav HP; Kapoor R
    J Clin Exp Hepatol; 2025; 15(1):102386. PubMed ID: 39282593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    Young S; Golzarian J
    AJR Am J Roentgenol; 2020 Jul; 215(1):223-234. PubMed ID: 32255691
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
    PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Therapies for Hepatocellular Carcinoma and Role of MRI-Guided Adaptive Radiation Therapy.
    Liu Y; Chou B; Yalamanchili A; Lim SN; Dawson LA; Thomas TO
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.
    Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T
    Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis.
    Patel MV; Davies H; Williams AO; Bromilow T; Baker H; Mealing S; Holmes H; Anderson N; Ahmed O
    J Med Econ; 2023; 26(1):1061-1071. PubMed ID: 37632520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective.
    Narayanan A; Garza-Berlanga A; Lopera J
    Ann Palliat Med; 2023 Nov; 12(6):1244-1259. PubMed ID: 37574584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
    Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy.
    Bauer U; Gerum S; Roeder F; Münch S; Combs SE; Philipp AB; De Toni EN; Kirstein MM; Vogel A; Mogler C; Haller B; Neumann J; Braren RF; Makowski MR; Paprottka P; Guba M; Geisler F; Schmid RM; Umgelter A; Ehmer U
    World J Gastroenterol; 2021 Jun; 27(24):3630-3642. PubMed ID: 34239274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
    Kim DY; Han KH
    Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma.
    Behzadi AH; Haghani L; D'Souza DL; Flanagan S; Jones C
    Semin Intervent Radiol; 2024 Feb; 41(1):48-55. PubMed ID: 38495267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current locoregional therapies and treatment strategies in hepatocellular carcinoma.
    Cardarelli-Leite L; Hadjivassiliou A; Klass D; Chung J; Ho SGF; Lim HJ; Kim PTW; Mujoomdar A; Liu DM
    Curr Oncol; 2020 Nov; 27(Suppl 3):S144-S151. PubMed ID: 33343208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma.
    Chami P; Jarnagin W; Abou-Alfa GK; Harding J; Kim N; Lin H; El Homsi M; Crane C; Hajj C
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.